CONTRACT AWARDUpdated 12 days ago

Natalizumab 20mg/ml - monoclonal Antibody - Vial (I.V)

World Bank-financed contract awarded to RAMCO PHARM for the Egypt, Arab Republic of Transforming Egypt's Healthcare System Project project (Project ID P167000).

Key Information
Awarded by
Government of Egypt, Arab Republic of (World Bank-financed, project P167000)
Location
Egypt, Arab Republic of, Egypt
Status
Awarded
Category
Goods
Award Amount
USD 506,149
Size
medium
Reference
1799405
Procurement Method
Direct Selection
Language
en
Awarded to
RAMCO PHARM

Overview

Contract awarded under World Bank-financed project P167000 (Transforming Egypt's Healthcare System Project). Borrower: Government of Egypt, Arab Republic of. Procurement category: Goods. Method: Direct Selection. Review type: Post. Fiscal year: 2025. Supplier of record (per World Bank STEP): RAMCO PHARM (Egypt, Arab Republic of). Borrower contract ref: CERC-UPA-GO-DIR-01. Source: World Bank Contract Awards in Investment Project Financing dataset, daily updated from STEP.

Selection Criteria

Selected through Direct Selection procurement procedure under World Bank Procurement Regulations. Procurement category: Goods. Subject to Post review by the World Bank.

Source: World Bank Contract Awards Dataset (DS00005), Project P167000 - Transforming Egypt's Healthcare System Project